Eine Aktie für die Watchliste ! ! ! !

Spire Corp.

Kürzel:   SPIR
WKN: 870534

Einfach mal die weitere Entwicklung beobachten !!!

"Spire Corporation is the world's leading supplier of the tools to manufacture photovoltaic (PV) modules. For more than twenty years, Spire has been supplying module manufacturing equipment and related technology worldwide, establishing strong relationships with more than 100 customers. Now, the PV industry is expanding rapidly due to the demand for wireless power for telecommunications and opportunities created by electric utility deregulation.”  

“Spire Corporation will further capitalize on this growing market by concentrating its energy and resources on leveraging its technology, PV business development know-how and worldwide customer relationships to provide new equipment, production lines, and solar energy businesses. Spire is investing in marketing and product development to aggressively pursue its Solar Brightfield™ strategy."

“Spire is offering turnkey PV module factories to the electric power industry to address new opportunities created by the need for reliable premium power, electric utility deregulation, the demand for clean energy, and the desire to revitalize utility owned brownfields.  The first of these factories, Spire Solar Chicago, will produce the world's largest PV array to convert an environmental brownfield into a Solar Brightfield™ with ComEd, the local utility, and the city of Chicago as partners."

Spire Biomedical Inc. Positioned for Independence

“For more than 15 years, Spire Biomedical has been a world leader in providing surface treatment services to the medical device industry to improve the performance of implantable devices.  Spurred by the aging population, demand for Spire Biomedical IonGuard™ branded orthopedic surface treatments is increasing.”  

“Spire Biomedical is investing in product development targeting growth segments of the orthopedic device market by offering surface treatments for bone integration of prosthetic devices and, eventually, coatings for tissue growth.  Spire Biomedical is also moving toward vertical integration into medical devices by introducing surface engineered renal care catheters. The incorporation of Spire Biomedical will permit it to more rapidly exploit the opportunities before it.”

Stock Dividend  

Mr. Little went on to say, "In addition to creating Spire Biomedical Inc. as a separate corporation, Spire Corporation's Board of Directors has declared a stock dividend for stockholders of record on November 22, 2000 to be paid on December 22, 2000. The stock dividend will consist of one share of Spire common stock for every outstanding share. Included in the stock dividend pool will be 552,160 shares of Spire Corporation treasury stock."

Increasing Spire's stock float will improve its liquidity making it easier for institutions and individual investors to purchase Spire stock, broadening ownership in the Company. Creating more shares will also give Spire added flexibility in possible future business actions such as acquisitions."

"These restructuring steps have been taken as part of our continuing plan to increase stockholder value by giving the Corporation the opportunity and flexibility to grow by exploiting its unique solar and biomedical technologies, their market positions, capital resources, and the operations that we took years to build."

Spire Corporation
Spire Corporation is the world's largest supplier of photovoltaic module manufacturing equipment, turnkey production lines, and solar energy businesses with equipment in 144 customer facilities in 39 countries worldwide.  Through its subsidiary, Spire Biomedical Inc., Spire Corporation is a leader in providing surface engineering treatments to orthopedic and other implantable medical devices to improve their performance in the body."  

Leider hab ich noch keine Quartalsberichte gefunden. Nur den Jahresbericht von `98

qccharts.quicken.com/bin/...6+97+98+99&gdf=gdonb&ldf=mc&alt=d" style="max-width:560px" >

...nicht sehr berauschend, Gewinne ok.
Erstmal Watchliste.

Gruß
TGK

Quelle:
quicken.excite.com/investments/seceval/?symbol=SPIR

Na ja, mit pushen will das jetzt mal nicht vergleichen, war es doch erstmal ein kleiner Wink den Wert auf die Watchliste zu nehmen. Deswegen gleich "unbegründetes pushen" zu vergeben find ich lächerlich???

Bestimmt ist SPIR ein interessanter Wert, P/E 7.6, Weltmarktführer in einer Sparte, die unsere Zukunft und die Energiewirtschaft in den nächsten Jahrzehnten bestimmen wird. Jedoch haben wir vorerst noch zu wenig Infos zusammengetragen:
Warum der Umsatzknick im Jahr 97?
Warum das enorme Gewinnplus?


TGK

Biotochter ausgliedern uns es einen Split geben wird.
Bis zum 22.11 läuft das Baby. Mit der Watchlist hat das nichts zu tun.

Langsam wirds lächerlich...

Das erste Mal, dass ich mich über das Bewertungssystem wirklich ärgern muß.

Unbegründetes Pushen ist für mich wenn jemand schreibt: "Tomorrow unbedingt kaufen. Das ist ein geiler Wert !" Und nicht wenn jemand einen interssanten Wert nennt. Davon lebt doch das Forum. Viele lesen das und vielleicht kennt jemand die Aktie und kann uns Infos geben.
Bitte beurteilt mal objektiv ! Sonst hat das keinen Sinn !

``During this quarter, we shipped equipment both domestically and internationally and began the manufacture of the equipment line which will be used by Spire Solar Chicago. Because of the delay in availability of the building to be provided by the City of Chicago, we entered into a lease agreement for temporary space in Chicago located at 2041 West Carroll Street, Suite C-128. This space will be used to house the equipment which we are building and plan to ship later this year and will allow us to begin manufacturing modules for ComEd, while we work with the City on permanent space currently under design by the City. We also announced during the quarter, the plan to work with the City and ComEd to deploy a 500 kW photovoltaic system on a reclaimed industrial landfill on Chicago's South Side, converting a ''brownfield`` to a ''Solar Brightfield(TM)``. Two other Chicago PV orders received this quarter were for the Nature Museum and the Shedd Aquarium.''

``Spire Solar uses its core photovoltaic module manufacturing equipment and technology to market PV module factories to utilities and other energy industry participants to take advantage of the opportunities created by utility deregulation and environmental cleanup in the United States and offers energy industry companies worldwide the opportunity to participate in this growing industry.''

Spire Biomedical

``Spire Biomedical continues to experience increasing demand for its processing services. As a result, steps were taken in the quarter ended 30 June 2000 to increase production capacity.''

Spire operates in two independent divisions as a leader providing products and services in two different market segments. Spire Solar is the world's largest supplier of photovoltaic manufacturing equipment, technology, and turn-key production lines for the assembly of terrestrial photovoltaic modules from solar cells, with equipment in 144 customer facilities in 39 countries worldwide. Spire Biomedical improves the performance of implantable medical devices through surface engineering treatments.

Certain matters discussed in this News Release may be forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risk of dependence on government agencies and other third parties for funding contract research and services, as well as other factors described in the Company's Form 10-KSB filed with the Securities and Exchange Commission.

-0-



                  SPIRE CORPORATION AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                     Three Months Ended         Six Months Ended
                           June 30                  June 30,
                      2000        1999          2000         1999

Net sales and
revenues          $ 3,159,000  $ 2,682,000  $ 7,691,000  $ 6,499,000

Loss from operations  (590,000)    (537,000)    (242,000)    (659,000)

Earnings (loss)
before income taxes  (472,000)    (558,000)       1,000     (707,000)
Income tax
expense (benefit)    (206,000)        --           --           --

Net earnings
(loss)            $  (266,000) $  (558,000) $     1,000  $  (707,000)

Earnings (loss)
per share of
common stock
- basic           $     (0.08) $     (0.17) $      0.00  $     (0.22)

Earnings (loss)
per share of
common stock
- diluted         $     (0.08) $     (0.17) $      0.00  $     (0.22)

Weighted average
number of common
and common equivalent
shares outstanding
- basic             3,313,840    3,244,183    3,303,211    3,243,945

Weighted average
number of common
and common equivalent
shares outstanding
- diluted           3,313,840    3,244,183    3,383,765    3,243,945


SUMMARY OF CONDENSED CONSOLIDATED BALANCE SHEETS

                                           June 30,    December 31,
                                             2000          1999

Assets
   Current assets                         $12,075,000   $15,229,000
   Net property and equipment               2,135,000     2,019,000
   Other assets                               110,000       115,000
       Total assets                       $14,320,000   $17,363,000

Liabilities and Stockholders' Equity
   Current liabilities                    $ 2,299,000   $ 5,511,000
   Stockholders' equity                    12,021,000    11,852,000
       Total liabilities and
        stockholders' equity              $14,320,000   $17,363,000


--------------------------------------------------
Contact:

    Spire Corporation
    Richard S. Gregorio, 781/275-6000
    Vice President & Chief Financial Officer

die läuft ja ganz nett...15$ jetzt schon. Allerdings halt Miniumsätze. Das nervt etwas.

auf die Nasdaq :-). Läuft und lauft....

Mal sehen was wird :-)...
Am Freitag ein Rücksetzer um 9%, der den Indikatoren allerdings gut getan hat. Chart sieht schön aus.

-20%, vielleicht kommen die Zahlen erst heute.

     sales mix has changed and our cost structure has been greatly reduced. This has resulted in a significant reduction in losses
     compared to a year ago."

     "We have begun to ship PV products out of our Spire Solar Chicago operations, installing over $300,000 in systems this quarter. We
     had anticipated booking approximately $400,000 in sales of PV manufacturing equipment purchased by our partner BP Solarex for
     our Chicago factory. However, the Company has not yet recognized any revenue, as the criteria for revenue recognition has not yet
     been met."

     Recent Corporate Actions

     On October 25, 2000, Spire made an important corporate change that bears on the futures of both businesses. Spire announced that
     it formed "Spire Biomedical Inc." as a wholly-owned subsidiary and declared a dividend of one share of Spire Corporation common
     stock for each outstanding share.

     Roger Little said, "Separating Spire into two autonomous, market-driven entities is part of our continuing plan to focus Spire as a `pure
     play' in the solar energy industry to increase stockholder value. It has been difficult for the financial markets to understand our
     Company with totally-different businesses. This focus began with the sale of our optoelectronic assets at the end of last year. Now,
     with its own identity, Spire Biomedical can more easily pursue its own corporate development activities, strategic partnerships, and
     acquire its own capital."

     The dividend will be distributed on December 22, 2000, to shareholders of record on November 22, 2000. Included in the dividend are
     552,160 shares of treasury stock that the Company now holds. The stock dividend increases Spire's float to make it easier for
     institutions and individual investors to purchase stock.

     Spire Solar Activities

     Spire Solar uses its core PV module manufacturing technology to focus on providing equipment, turnkey factories, and solar energy
     businesses to customers worldwide.

     Mr. Little said, "The growth of our fundamental commercial business of PV equipment is consistent with market trends. However, we
     are investing in new product development, marketing, and building a stronger staff to take the Company to new levels of revenue
     generation and profitability. Investments were particularly heavy in start-up costs for our Spire Solar Chicago operations."

     Spire is also investing in its core technology of PV module manufacturing equipment to maintain its position as the world leader. Spire
     continues to cost share on its $3 million Department of Energy equipment development contract and has begun to market new
     equipment developed under that program. Among other equipment orders, Spire has recently received an order from Siemens Solar
     for manufacturing equipment totaling about $1 million. Spire has also added new staff in equipment engineering and manufacturing.

     Mr. Little further said, "Spire Solar Chicago was established with a guaranteed $8 million market from the City of Chicago and ComEd,
     the local utility. This market opportunity has more than doubled by leveraging the state program for PV system purchases and the
     announcement by ComEd that a Solar Brightfield array will be put on a local brownfield. To prepare for this growth, Spire has invested
     in building up engineering, marketing, and manufacturing staff in Chicago."

     "We have added key marketing staff to lead Spire's efforts to establish other "Spire Solar Chicago's" in other cities throughout the
     United States by partnering with local utilities to convert environmental brownfields into Solar Brightfields. This takes advantage of new
     opportunities created by electric utility deregulation and the demand for clean, reliable power."

     Spire Biomedical Activities

     Spire Biomedical uses its core surface and materials technologies to provide products and services for improved implantable medical
     devices with a focus on orthopedics.

     Mr. Little said, "Spire Biomedical has been adding to its infrastructure in the form of key staff and investing in new capital equipment to
     increase its production capacity for our IonGuard(TM) orthopedic surface treatments because of a growing market. Spire Biomedical
     received ISO-9001 certification, demonstrating the Company's commitment to provide its customers with the highest quality processing
     services."

     "In order to achieve the growth rate that we are targeting, Spire Biomedical is investing in developing a new generation of tissue
     engineering surface treatments for the orthopedic market. These treatments result in bone integration of prosthetic devices and
     eventually may even be able to cause new tissue to grow."

     About Spire Corporation

     Spire Corporation is the world's largest supplier of photovoltaic module manufacturing equipment, turnkey production lines, and solar
     energy businesses with equipment in 144 customer facilities in 39 countries worldwide. Spire Biomedical is a leader in providing
     surface treatments to orthopedic and other implantable medical devices to improve their performance in the body.

     Certain matters discussed in this News Release may be forward-looking statements subject to risks and uncertainties that could cause
     actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are
     not limited to, the risk of dependence on government agencies and other third parties for funding contract research and services, as
     well as other factors described in the Company's Form 10-KSB filed with the Securities and Exchange Commission.

     Visit our web site at www.spirecorp.com.

                        SPIRE CORPORATION AND SUBSIDIARY



     CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                             Three Months Ended         Nine Months Ended
                                September 30,              September 30,
                             2000         1999          2000          1999

     Net sales
      and revenues     $2,826,000   $2,722,000   $10,517,000   $ 9,221,000

     Loss from
      operations         (546,000)    (829,000)     (788,000)   (1,488,000)

     Loss before
      income taxes       (426,000)    (862,000)     (425,000)   (1,570,000)
     Income tax
      expense (benefit)  (299,000)        --        (299,000)         --

     Net loss          $ (127,000)  $ (862,000)  $  (127,000)  $(1,570,000)

     Loss per
      share of
      common stock
      - basic          $    (0.04)  $    (0.27)  $     (0.04)  $     (0.48)

     Loss per
      share of
      common stock
      - diluted        $    (0.04)  $    (0.27)  $     (0.04)  $     (0.48)

     Weighted average
      number of common
      and common
      equivalent
      shares
      outstanding
      - basic           3,318,317    3,245,016     3,307,743     3,244,266

     Weighted average
      number of common
      and common
      equivalent
      shares
      outstanding
      - diluted         3,318,317    3,245,016     3,307,743     3,244,266


     SUMMARY OF CONDENSED CONSOLIDATED BALANCE SHEETS

                                            September 30,     December 31,
                                                 2000             1999

     Assets
      Current assets                        $13,082,000      $15,229,000
      Net property and equipment              2,161,000        2,019,000
      Other assets                              118,000          115,000
       Total assets                         $15,361,000      $17,363,000

     Liabilities and Stockholders' Equity
      Current liabilities                   $ 3,413,000      $ 5,511,000
      Stockholders' equity                   11,948,000       11,852,000
       Total liabilities and
        stockholders' equity                $15,361,000      $17,363,000

     CONTACT:          Spire Corporation
                       Richard S. Gregorio
                       Vice President & Chief Financial Officer
                       781-275-6000

     URL:              www.businesswire.com
     Today's News On The Net - Business Wire's full file on the Internet
     with Hyperlinks to your home page.

     Copyright (C) 2000 Business Wire. All rights reserved.

Roger G. Little, President and CEO of Spire Corporation, said, ``During this quarter, we continued to transition out of our optoelectronics research and development contract activities. We solidified both our solar and biomedical commercial businesses and are now investing in the future. While sales increased a modest 4% for the quarter and 15% year-to-date compared to last year, our sales mix has changed and our cost structure has been greatly reduced. This has resulted in a significant reduction in losses compared to a year ago.''

``We have begun to ship PV products out of our Spire Solar Chicago operations, installing over $300,000 in systems this quarter. We had anticipated booking approximately $400,000 in sales of PV manufacturing equipment purchased by our partner BP Solarex for our Chicago factory. However, the Company has not yet recognized any revenue, as the criteria for revenue recognition has not yet been met.''

Recent Corporate Actions

On October 25, 2000, Spire made an important corporate change that bears on the futures of both businesses. Spire announced that it formed ``Spire Biomedical Inc.'' as a wholly-owned subsidiary and declared a dividend of one share of Spire Corporation common stock for each outstanding share.

Roger Little said, ``Separating Spire into two autonomous, market-driven entities is part of our continuing plan to focus Spire as a `pure play' in the solar energy industry to increase stockholder value. It has been difficult for the financial markets to understand our Company with totally-different businesses. This focus began with the sale of our optoelectronic assets at the end of last year. Now, with its own identity, Spire Biomedical can more easily pursue its own corporate development activities, strategic partnerships, and acquire its own capital.''

The dividend will be distributed on December 22, 2000, to shareholders of record on November 22, 2000. Included in the dividend are 552,160 shares of treasury stock that the Company now holds. The stock dividend increases Spire's float to make it easier for institutions and individual investors to purchase stock.

Spire Solar Activities

Spire Solar uses its core PV module manufacturing technology to focus on providing equipment, turnkey factories, and solar energy businesses to customers worldwide.

Mr. Little said, ``The growth of our fundamental commercial business of PV equipment is consistent with market trends. However, we are investing in new product development, marketing, and building a stronger staff to take the Company to new levels of revenue generation and profitability. Investments were particularly heavy in start-up costs for our Spire Solar Chicago operations.''

Spire is also investing in its core technology of PV module manufacturing equipment to maintain its position as the world leader. Spire continues to cost share on its $3 million Department of Energy equipment development contract and has begun to market new equipment developed under that program. Among other equipment orders, Spire has recently received an order from Siemens Solar for manufacturing equipment totaling about $1 million. Spire has also added new staff in equipment engineering and manufacturing.

Mr. Little further said, ``Spire Solar Chicago was established with a guaranteed $8 million market from the City of Chicago and ComEd, the local utility. This market opportunity has more than doubled by leveraging the state program for PV system purchases and the announcement by ComEd that a Solar Brightfield array will be put on a local brownfield. To prepare for this growth, Spire has invested in building up engineering, marketing, and manufacturing staff in Chicago.''

``We have added key marketing staff to lead Spire's efforts to establish other ''Spire Solar Chicago's`` in other cities throughout the United States by partnering with local utilities to convert environmental brownfields into Solar Brightfields. This takes advantage of new opportunities created by electric utility deregulation and the demand for clean, reliable power.''

Spire Biomedical Activities

Spire Biomedical uses its core surface and materials technologies to provide products and services for improved implantable medical devices with a focus on orthopedics.

Mr. Little said, ``Spire Biomedical has been adding to its infrastructure in the form of key staff and investing in new capital equipment to increase its production capacity for our IonGuard(TM) orthopedic surface treatments because of a growing market. Spire Biomedical received ISO-9001 certification, demonstrating the Company's commitment to provide its customers with the highest quality processing services.''

``In order to achieve the growth rate that we are targeting, Spire Biomedical is investing in developing a new generation of tissue engineering surface treatments for the orthopedic market. These treatments result in bone integration of prosthetic devices and eventually may even be able to cause new tissue to grow.''

About Spire Corporation

Spire Corporation is the world's largest supplier of photovoltaic module manufacturing equipment, turnkey production lines, and solar energy businesses with equipment in 144 customer facilities in 39 countries worldwide. Spire Biomedical is a leader in providing surface treatments to orthopedic and other implantable medical devices to improve their performance in the body.

Certain matters discussed in this News Release may be forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risk of dependence on government agencies and other third parties for funding contract research and services, as well as other factors described in the Company's Form 10-KSB filed with the Securities and Exchange Commission.

Visit our web site at www.spirecorp.com.


                  SPIRE CORPORATION AND SUBSIDIARY



CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                       Three Months Ended         Nine Months Ended
                          September 30,              September 30,
                       2000         1999          2000          1999

Net sales
and revenues     $2,826,000   $2,722,000   $10,517,000   $ 9,221,000

Loss from
operations         (546,000)    (829,000)     (788,000)   (1,488,000)

Loss before
income taxes       (426,000)    (862,000)     (425,000)   (1,570,000)
Income tax
expense (benefit)  (299,000)        --        (299,000)         --

Net loss          $ (127,000)  $ (862,000)  $  (127,000)  $(1,570,000)

Loss per
share of
common stock
- basic          $    (0.04)  $    (0.27)  $     (0.04)  $     (0.48)

Loss per
share of
common stock
- diluted        $    (0.04)  $    (0.27)  $     (0.04)  $     (0.48)

Weighted average
number of common
and common
equivalent
shares
outstanding
- basic           3,318,317    3,245,016     3,307,743     3,244,266

Weighted average
number of common
and common
equivalent
shares
outstanding
- diluted         3,318,317    3,245,016     3,307,743     3,244,266


SUMMARY OF CONDENSED CONSOLIDATED BALANCE SHEETS

                                      September 30,     December 31,
                                           2000             1999

Assets
Current assets                        $13,082,000      $15,229,000
Net property and equipment              2,161,000        2,019,000
Other assets                              118,000          115,000
 Total assets                         $15,361,000      $17,363,000

Liabilities and Stockholders' Equity
Current liabilities                   $ 3,413,000      $ 5,511,000
Stockholders' equity                   11,948,000       11,852,000
 Total liabilities and
  stockholders' equity                $15,361,000      $17,363,000

auch einige Brennstoffzellenwerte wie HPOW und SATC in den letzten Tagen sehr gut gelaufen,nur ist hier absehbar,dass SPIR demnächst schwarze Zahlen haben mit ihren Solarzellen.Wie sind da eigentlich die Preise?Ich weiss aus Erfahrung von den Bermudas wie wichtig die Dinger auf den Inseln sind,und bisher sehr teuer in USA,so dass ein Bekannter eine als Spiegel verkleidet aus Deutschland importierte.Werde mich mal informieren.

eigentlich weniger Solarzellen....
sondern mehr Maschinen zur Produktion von Zellen + Wavern. Aber in Chicago fertigen sie auch selber
Die Range kann man sich sehr schön unter www.spirecorp.com anschauen.
 

Eine Photovoltaikanlage mit 6 KW Maximalleistung kostet knapp 75.000 DM!

Morgen ist ja Feiertag in USA, daher letzte Möglichkeit vor dem Stock-Dividend Date zu kaufen.
Jetzt haben wir einen größeren Float und evtl. ein paar mehr Instis als Käufer (bisher 7 !? mit minimalen Holdings).  

das ist eine völlig neue Erfahrung für mich.  

Würde sagen...guter Deal, so um die 50%.
Ich habe heute Untersuchungen gelesen über SPIR und den PV Markt in den nächsten 5 Jahren. Ich denke das Ding kommt mal in die "evtl. langfrist Ecke"...kommt auf das Management an. Kann man noch nicht so richtig einschätzen wg. der Geschäftsfeldveränderungen und der Chicago Investition. Ich hoffe aber die lohn...und auch der Siemens Auftrag für 1Mio.$...:-)
pushpushpush...man möge mir vergeben.

As soon as I read the latest Coolcat Aggressive stock pick list recommending SPIR, I immediately sold out at 16!!!
Now look at it....'in pieces'! ist einer der letzten Beiträge bei www.clearstation.com
im 3-Monatschart hier ist der MACD noch unter Null,der RSI bei fast 70,auch die Stochastic ist bereits gestiegen.Spir will offenbar den Solarenergiebereich von der Biotechnologie erst noch trennen ,bestenfalls Watchlist

Blödsinn. Schau mal genau hin (+Splittermin)...
So eine unqualifizierte Antwort hätte ich nicht erwartet....aber ist ja auch eines meiner Favoriten Investments...

und um andere zum Kauf zu verlocken ,halte ich das momentan für zu früh,wir haben doch alle genug verloren.

Man möge mir dann halt meine Begeisterung für diesen Stock verzeihen. Aber daß das Ding schön laufen wird nach Anlauf der Chicago Plant ist eigentlich sicher.
Einzige Frage: Der Float hat sich jetzt zwar verdoppelt. Aber reicht die Menge für Instis?

Gruß
Drogo